COVID-19 antiviral treatment remains critically important in 2026 for San Francisco's large immunocompromised population — including HIV-positive individuals, transplant recipients, haematology patients, and the elderly — all of whom face significantly higher risk of severe COVID-19 disease progression. Molnulee, generic Molnupiravir from Unnati Pharmax, provides this essential antiviral at competitive wholesale pricing.
Molnulee works by introducing errors into the SARS-CoV-2 virus's RNA replication process through a mechanism called lethal mutagenesis, causing the virus to accumulate so many copying errors that it can no longer reproduce effectively. The standard course is 800mg (four 200mg capsules) twice daily for 5 days, ideally initiated within 5 days of symptom onset in high-risk adult patients.
San Francisco's major hospitals, community pharmacies, and infectious disease clinics serving immunocompromised patients can source Molnulee at competitive institutional pricing with full WHO-GMP documentation. Visit medshopy.com or WhatsApp +91 82650 41513.
Molnulee works by introducing errors into the SARS-CoV-2 virus's RNA replication process through a mechanism called lethal mutagenesis, causing the virus to accumulate so many copying errors that it can no longer reproduce effectively. The standard course is 800mg (four 200mg capsules) twice daily for 5 days, ideally initiated within 5 days of symptom onset in high-risk adult patients.
San Francisco's major hospitals, community pharmacies, and infectious disease clinics serving immunocompromised patients can source Molnulee at competitive institutional pricing with full WHO-GMP documentation. Visit medshopy.com or WhatsApp +91 82650 41513.
Can Molnulee be used in patients who are also on HIV antiretroviral therapy?Generally yes — Molnupiravir has a favourable drug interaction profile and does not significantly interact with most HIV antiretroviral medications. However, patients on complex antiretroviral regimens should always check with their HIV specialist or pharmacist before starting any new medication, including Molnulee, to confirm there are no specific interactions relevant to their individual treatment combination
